An injection designed to tackle obesity could reduce the risk of heart attacks and strokes – regardless of how much weight they lose while on the drug, according to a new study.
Researchers looked at the effects of semaglutide – which is a prescription drug that suppresses appetite and is sold under the brand names Wegovy, Ozempic and Rybelsus.
They said the anti-obesity jabs could also benefit the cardiovascular health of millions of adults, with one researcher likening it to when statins were introduced in the 1990s.
Subscribe here: http://bit.ly/1rbfUog
For more news, analysis and features visit: www.bbc.com/news
#Ozempic #WeightLoss #BBCNews
US President Donald Trump made more than $1bn (£750m) last year from business dealings in cryptocurrency, according to his mandatory…
A woman who was raped by Superdry co-founder James Holder has told the BBC she had been working for him…
MILANO (ITALPRESS) – “Chang”, che in cinese significa lunga durata e “An”, che vuol dire pace e stabilità. Dall’unione di…
Sudanese paramilitaries committed crimes against humanity and ethnic cleansing during their campaign to seize the city of el-Fasher last year,…
ANSA è la più importante agenzia d'informazione in Italia. Immagini e storie da tutto il mondo: politica, economia, cronaca, sport,…
The United Nations said tens of thousands of Venezuelans face hunger, homelessness and disease, as the country struggles with the…